Lista de obras - Simon Heeke - Dominio Público Uruguay

Alternative splicing of P2RX7 pre-messenger RNA in health and diseases: Myth or reality?

scientific article published on 01 June 2019

Any Place for Immunohistochemistry within the Predictive Biomarkers of Treatment in Lung Cancer Patients?

artículo científico publicado en 2018

Circulating Tumor Cell Detection in Lung Cancer: But to What End?

artículo científico publicado en 2019

Correction for Wu et al., "Salmonella Utilizes Zinc To Subvert Antimicrobial Host Defense of Macrophages via Modulation of NF-κB Signaling".

artículo científico publicado en 2018

Critical Assessment in Routine Clinical Practice of Liquid Biopsy for EGFR Status Testing in Non-Small-Cell Lung Cancer: A Single-Laboratory Experience (LPCE, Nice, France)

artículo científico publicado en 2019

Current views on tumor mutational burden in patients with non-small cell lung cancer treated by immune checkpoint inhibitors

artículo científico publicado en 2019

DNAshell Protects DNA Stored at Room Temperature for Downstream Next-Generation Sequencing Studies

scientific article published on 26 March 2019

Ensuring the Safety and Security of Frozen Lung Cancer Tissue Collections through the Encapsulation of Dried DNA.

artículo científico publicado en 2018

Establishing a Dedicated Lung Cancer Biobank at the University Center Hospital of Nice (France). Why and How?

artículo científico publicado en 2018

Immunotherapy in Non-Small Cell Lung Cancer: Biological Principles and Future Opportunities

artículo científico publicado en 2018

In-house Implementation of Tumor Mutational Burden Testing to Predict Durable Clinical Benefit in Non-small Cell Lung Cancer and Melanoma Patients

scientific article published on 29 August 2019

Liquid biopsy in the era of immuno-oncology: is it ready for prime-time use for cancer patients?

scientific article published on 01 September 2019

Lung Cancer Models Reveal Severe Acute Respiratory Syndrome Coronavirus 2-Induced Epithelial-to-Mesenchymal Transition Contributes to Coronavirus Disease 2019 Pathophysiology

artículo científico publicado en 2021

Multicenter Evaluation of a Novel ROS1 Immunohistochemistry Assay (SP384) for Detection of ROS1 Rearrangements in a Large Cohort of Lung Adenocarcinoma Patients

scientific article published on 15 April 2019

NGS analysis on tumor tissue and cfDNA for genotype-directed therapy in metastatic NSCLC patients. Between hope and hype?

artículo científico publicado en 2017

Never Travel Alone: The Crosstalk of Circulating Tumor Cells and the Blood Microenvironment

artículo científico publicado en 2019

Optimization of EGFR mutation detection by the fully-automated qPCR-based Idylla system on tumor tissue from patients with non-small cell lung cancer.

artículo científico publicado en 2017

Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities

artículo científico publicado en 2021

Prospective evaluation of NGS-based liquid biopsy in untreated late stage non-squamous lung carcinoma in a single institution

artículo científico publicado en 2020

Structure-based classification predicts drug response in EGFR-mutant NSCLC

artículo científico publicado en 2021

Targeted Assessment of the EGFR Status as Reflex Testing in Treatment-Naive Non-Squamous Cell Lung Carcinoma Patients: A Single Laboratory Experience (LPCE, Nice, France)

scientific article published on 13 April 2020

Tumor mutational burden assessment as a predictive biomarker for immunotherapy in lung cancer patients: getting ready for prime-time or not?

artículo científico publicado en 2018

Use of circulating tumor cells in prospective clinical trials for NSCLC patients - standardization of the pre-analytical conditions.

artículo científico publicado en 2018

Use of the Ion PGM and the GeneReader NGS Systems in Daily Routine Practice for Advanced Lung Adenocarcinoma Patients: A Practical Point of View Reporting a Comparative Study and Assessment of 90 Patients.

artículo científico publicado en 2018

[The age of artificial intelligence in lung cancer pathology: Between hope, gloom and perspectives]

artículo científico publicado en 2019

Lista de obras de Simon Heeke

Alternative splicing of P2RX7 pre-messenger RNA in health and diseases: Myth or reality?

Any Place for Immunohistochemistry within the Predictive Biomarkers of Treatment in Lung Cancer Patients?

Circulating Tumor Cell Detection in Lung Cancer: But to What End?

Correction for Wu et al., "Salmonella Utilizes Zinc To Subvert Antimicrobial Host Defense of Macrophages via Modulation of NF-κB Signaling".

Critical Assessment in Routine Clinical Practice of Liquid Biopsy for EGFR Status Testing in Non-Small-Cell Lung Cancer: A Single-Laboratory Experience (LPCE, Nice, France)

Current views on tumor mutational burden in patients with non-small cell lung cancer treated by immune checkpoint inhibitors

DNAshell Protects DNA Stored at Room Temperature for Downstream Next-Generation Sequencing Studies

Ensuring the Safety and Security of Frozen Lung Cancer Tissue Collections through the Encapsulation of Dried DNA.

Establishing a Dedicated Lung Cancer Biobank at the University Center Hospital of Nice (France). Why and How?

Immunotherapy in Non-Small Cell Lung Cancer: Biological Principles and Future Opportunities

In-house Implementation of Tumor Mutational Burden Testing to Predict Durable Clinical Benefit in Non-small Cell Lung Cancer and Melanoma Patients

Liquid biopsy in the era of immuno-oncology: is it ready for prime-time use for cancer patients?

Lung Cancer Models Reveal Severe Acute Respiratory Syndrome Coronavirus 2-Induced Epithelial-to-Mesenchymal Transition Contributes to Coronavirus Disease 2019 Pathophysiology

Multicenter Evaluation of a Novel ROS1 Immunohistochemistry Assay (SP384) for Detection of ROS1 Rearrangements in a Large Cohort of Lung Adenocarcinoma Patients

NGS analysis on tumor tissue and cfDNA for genotype-directed therapy in metastatic NSCLC patients. Between hope and hype?

Never Travel Alone: The Crosstalk of Circulating Tumor Cells and the Blood Microenvironment

Optimization of EGFR mutation detection by the fully-automated qPCR-based Idylla system on tumor tissue from patients with non-small cell lung cancer.

Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities

Prospective evaluation of NGS-based liquid biopsy in untreated late stage non-squamous lung carcinoma in a single institution

Structure-based classification predicts drug response in EGFR-mutant NSCLC

Targeted Assessment of the EGFR Status as Reflex Testing in Treatment-Naive Non-Squamous Cell Lung Carcinoma Patients: A Single Laboratory Experience (LPCE, Nice, France)

Tumor mutational burden assessment as a predictive biomarker for immunotherapy in lung cancer patients: getting ready for prime-time or not?

Use of circulating tumor cells in prospective clinical trials for NSCLC patients - standardization of the pre-analytical conditions.

Use of the Ion PGM and the GeneReader NGS Systems in Daily Routine Practice for Advanced Lung Adenocarcinoma Patients: A Practical Point of View Reporting a Comparative Study and Assessment of 90 Patients.

[The age of artificial intelligence in lung cancer pathology: Between hope, gloom and perspectives]